Publications by authors named "Mitchell G Rands"
Mol Cancer Ther
February 2023
Article Synopsis
- - Prostate cancer is a serious global health issue with low survival rates in advanced stages, often progressing to a castration-resistant form after initial treatment failure.
- - Current treatments mainly target androgen receptors, but there's a pressing need for new drugs that focus on the oncogenes involved in prostate cancer development, particularly E-26 transformation-specific (ETS) transcription factors.
- - Research into various targeted therapies, including small molecules and nucleic acids, shows promise in inhibiting ETS activity, which could reduce tumor growth, though more studies are needed to understand their effects on both tumor and non-tumor tissues.
